The Ensign Group, Inc.
NASDAQ:ENSGMedical - Care Facilities
-$1.09 today
- Market cap
- $10.68B
- Beta
- 0.68
- P/E (TTM)
- 24.8
- EPS (TTM)
- $6.29
- Dividend yield
- 0.16%
Volume 0.27M
Average 0.56M
ENSG Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
The Ensign Group, Inc.NASDAQ: ENSG
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 27.9% from a year ago
Cash & equivalents stood at $262.3M at the end of Q2 FY2026, down 27.9% from a year earlier and down 51.4% from the prior quarter. Over 3 fiscal years it compounded at +16.8% a year.
Context
- Cash & equivalents amounted to 4.6% of total assets at the end of Q2 FY2026, down 2.8 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -27.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 503.88M USD
- Year-over-year change
- +8.5%
- 4-year CAGR
- +17.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 503.88M | +8.5% |
| FY2024 | 2024-12-31 | 464.6M | -8.8% |
| FY2023 | 2023-12-31 | 509.63M | +61.1% |
| FY2022 | 2022-12-31 | 316.27M | +20.6% |
| FY2021 | 2021-12-31 | 262.2M | — |
Cash & Equivalents vs competitors
How ENSG compares with its peers on the latest reported figures
- ENSG's Jun 2026 cash & equivalents of $262.3M is the 4th highest of the 11 companies compared; the peer median is $136.08M.
- Its year-over-year change of -27.9% is the 8th highest of 11, against a peer median of +1.0%.
- Cash & equivalents amounts to 4.6% of total assets for ENSG, versus a peer median of 3.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.01B | +7.9% | +4.6% | 1.7% | |
| Mar 2026 | $712M | +65.2% | +30.1% | 5.4% | |
| Sep 2026 | $323.37M | +27.6% | -11.2% | 5.5% | |
| Jun 2026 | $262.3M | -27.9% | +16.8% | 4.6% | |
| Oct 2026 | $197.84M | +35.6% | +115.9% | 9.0% | |
| Jun 2026 | $164.45M | -44.1% | +50.1% | 2.9% | |
| Jun 2026 | $107.7M | -21.6% | +67.7% | 1.4% | |
| Mar 2026 | $95.55M | +58.0% | -29.7% | 17.5% | |
| Sep 2026 | $66.8M | -48.9% | +23.7% | 3.2% | |
| Jun 2026 | $40.22M | -83.9% | +0.2% | 2.5% | |
| Mar 2026 | $4.91M | -5.9% | +101.6% | 0.5% | |
| Peer median (excluding ENSG) | $136.08M | +1.0% | +26.9% | 3.1% | |
Competitors are the stored peer set for ENSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 262.2M | 316.27M | 509.63M | 464.6M | 503.88M |
| Short-term Investments | 13.76M | 15.44M | 17.23M | 62.26M | 68.51M |
| Net Receivables | 328.73M | 408.43M | 485.04M | 569.9M | 636.99M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 29.56M | 36.34M | 35.04M | 60.88M | 62.93M |
| Total Current Assets | 639.71M | 781.13M | 1.05B | 1.16B | 1.27B |
| Property, Plant & Equipment (Net) | 2.03B | 2.44B | 2.85B | 3.15B | 3.79B |
| Goodwill | 60.47M | 76.87M | 76.87M | 97.98M | 97.98M |
| Intangible Assets | 6.38M | 6.44M | 6.53M | 7.29M | 6.38M |
| Long-term Investments | 0 | 0 | 0 | 0 | 166.84M |
| Tax Assets | 33.15M | 39.64M | 67.12M | 66.28M | 83.14M |
| Other Non-current Assets | 83.61M | 104.94M | 132.89M | 187.75M | 41.6M |
| Total Non-current Assets | 2.21B | 2.67B | 3.13B | 3.51B | 4.19B |
| Total Assets | 2.85B | 3.45B | 4.18B | 4.67B | 5.46B |
| Account Payables | 58.12M | 77.09M | 92.81M | 98.95M | 97.33M |
| Short-term Debt | 3.76M | 3.88M | 3.95M | 4.09M | 4.23M |
| Tax Payables | 9.12M | 10.93M | 12.88M | 15.4M | 0 |
| Deferred Revenue | 9.34M | 9.7M | 10.83M | 18.82M | 105.64M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 68.39M |
| Total Current Liabilities | 523.07M | 582.07M | 734.75M | 743.43M | 894.35M |
| Long-term Debt | 152.88M | 149.27M | 145.5M | 141.59M | 2.09B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 96.44M | 116.77M | 160.65M | 208.59M | (1.7B) |
| Total Non-current Liabilities | 1.31B | 1.62B | 1.95B | 2.09B | 2.33B |
| Total Liabilities | 1.83B | 2.2B | 2.68B | 2.83B | 3.23B |
| Common Stock | 58K | 59K | 60K | 61K | 62K |
| Retained Earnings | 733.99M | 946.34M | 1.14B | 1.43B | 1.76B |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 946K | 1.47M | 5.45M | 3.32M | 3.1M |
| Total Equity | 1.02B | 1.25B | 1.5B | 1.84B | 2.23B |
| Total Debt | 1.27B | 1.57B | 1.87B | 1.97B | 4.15B |
| Net Debt | 1B | 1.26B | 1.36B | 1.51B | 3.65B |
The Ensign Group, Inc.
NASDAQ:ENSG
Intrinsic Alpha fair value
Locked
Current Price
$182.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.